Tasman Pharma patents expiration
1. Versacloz patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8057811 | TASMAN PHARMA | Stable clozapine suspension formulation |
May, 2028
(4 years from now) | |
Drugs and Companies using CLOZAPINE ingredient
Market Authorisation Date: 06 February, 2013
Treatment: NA
Dosage: SUSPENSION;ORAL
More Information on Dosage
VERSACLOZ family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic